Lexicon Pharmaceuticals annual shares outstanding
2024
2025
Lexicon Pharmaceuticals Shares Outstanding History (LXRX)
Lexicon Pharmaceuticals reported 365.8M shares outstanding at the end of fiscal 2025.
View full Lexicon Pharmaceuticals company overviewLexicon Pharmaceuticals annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 365.8M | 2.8M | +0.78% |
| 2024 | 2024-12-31 | 363.0M | — | — |
Lexicon Pharmaceuticals quarterly shares outstanding
Q4.24
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 446.9M | 83.9M | +23.10% |
| Q1 2026 | 2026-03-31 | 425.7M | — | — |
| Q4 2025 | 2025-12-31 | 365.8M | — | — |
| Q3 2025 | 2025-09-30 | 365.8M | — | — |
| Q4 2024 | 2024-12-31 | 363.0M | — | — |
Lexicon Pharmaceuticals shares outstanding trends
Across the available reported history, Lexicon Pharmaceuticals's shares outstanding moved from 363.0M to 365.8M, a change of 2.8M. The latest reported quarter, Q2 2026, shows 446.9M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lexicon Pharmaceuticals filings at SEC.gov ↗